Department of Obstetrics, Perinatology University Hospital, 30-551 Kraków, Poland.
Hi-Gen Centrum Medyczne, 30-552 Kraków, Poland.
Viruses. 2023 Oct 24;15(11):2142. doi: 10.3390/v15112142.
Cytomegalovirus (CMV) infection is a significant health concern affecting numerous expectant mothers across the globe. CMV is the leading cause of health problems and developmental delays among infected infants. Notably, this study examines CMV infection in pregnancy, its management, prevention mechanisms, and treatment options.
Specifically, information from the Cochrane Library, PUBMED, Wiley Online, Science Direct, and Taylor Francis databases were reviewed along with additional records identified through the register, the Google Scholar search engine. Based on the search, 21 articles were identified for systematic review.
A total of six randomized controlled trials (RCTs) were utilized for a meta-analytic review. As heterogeneity was substantial, the random effects model was used for meta-analysis. Utilizing the random-effects model, the restricted maximum likelihood (REML) approach, the estimate of effect size (d = -0.479, 95% CI = -0.977 to 0.019, = 0.060) suggests the results are not statistically significant, so it cannot be inferred that the prevention methods used were effective, despite an inverse relationship between treatment and number of infected cases. The findings indicated that several techniques are used to prevent, diagnose, and manage CMV infection during pregnancy, including proper hygiene, ultrasound examination (US), magnetic resonance imaging (MRI), amniocentesis, viremia, hyperimmunoglobulin (HIG), and valacyclovir (VACV).
The current review has significant implications for addressing CMV infection in pregnancy. Specifically, it provides valuable findings on contemporary management interventions to prevent and treat CMV infection among expectant mothers. Therefore, it allows relevant stakeholders to address these critical health concerns and understand the effectiveness of the proposed prevention and treatment options.
巨细胞病毒(CMV)感染是一个重大的健康问题,影响着全球众多孕妇。CMV 是感染婴儿出现健康问题和发育迟缓的主要原因。值得注意的是,本研究检查了妊娠期间的 CMV 感染、其管理、预防机制和治疗选择。
具体而言,我们审查了 Cochrane 图书馆、PubMed、Wiley Online、Science Direct 和 Taylor Francis 数据库中的信息,以及通过注册、Google Scholar 搜索引擎识别的其他记录。根据搜索结果,确定了 21 篇文章进行系统评价。
共使用了六项随机对照试验(RCT)进行荟萃分析综述。由于存在很大的异质性,因此使用随机效应模型进行荟萃分析。使用随机效应模型、受限极大似然(REML)方法,效应量估计(d=-0.479,95%CI=-0.977 至 0.019, =0.060)表明结果不具有统计学意义,因此不能推断所使用的预防方法是有效的,尽管治疗与感染病例数之间存在反比关系。研究结果表明,有几种技术用于预防、诊断和管理妊娠期间的 CMV 感染,包括适当的卫生、超声检查(US)、磁共振成像(MRI)、羊膜穿刺术、病毒血症、高免疫球蛋白(HIG)和伐昔洛韦(VACV)。
本综述对处理妊娠期间的 CMV 感染具有重要意义。具体而言,它提供了有关当代管理干预措施的有价值的发现,以预防和治疗孕妇中的 CMV 感染。因此,它使相关利益相关者能够解决这些关键的健康问题,并了解所提出的预防和治疗选择的有效性。